Shingles Vaccine Market 2026 gaining traction with aging population demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Shingles Vaccine Market Between 2026 And 2030?

The shingles vaccine market has experienced substantial expansion in recent years. Projections indicate its value will increase from $5.55 billion in 2025 to $6.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Factors contributing to this historical growth include the initial limited availability of shingles vaccines, a past reliance on live attenuated vaccines, an expanding elderly demographic, a higher incidence of herpes zoster, and heightened awareness regarding the advantages of immunization.

The shingles vaccine market is projected for significant expansion in the coming years, anticipated to reach $10.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. This growth during the forecast period is propelled by factors such as the advancement of recombinant and subunit vaccines, the broadening scope of public and private vaccination efforts, wider use of online and retail pharmacy channels for distribution, escalating government and healthcare programs promoting immunization for seniors, and the incorporation of digital health monitoring to ensure vaccination adherence. Key trends expected over the forecast horizon encompass the growing embrace of recombinant and subunit shingles vaccines, heightened awareness regarding shingles prevention among the elderly, the proliferation of vaccination initiatives via hospitals and retail pharmacies, the expansion of online pharmacies and e-commerce for vaccine distribution, and a concentrated effort on age-specific immunization approaches targeting the 50+ demographic.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27413&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Shingles Vaccine Market?

A rising trend in vaccination initiatives is anticipated to stimulate the expansion of the shingles vaccine market in the future. These programs are structured public health efforts aimed at systematically delivering vaccines to communities to curb the dissemination of contagious illnesses. The proliferation of such programs stems from heightened public understanding of preventive healthcare, motivating individuals to seek vaccination for disease prevention. Through boosting public consciousness and improving access, these initiatives improve the uptake of the shingles vaccine, proving particularly beneficial for seniors and vulnerable groups. By facilitating prompt and broad immunization, they mitigate the danger of shingles and its associated complications, thus enhancing collective public health. For example, data from July 2025, provided by the World Health Organization, a Switzerland-based Intergovernmental organization, indicates that the coverage for the initial dose of the human papillomavirus (HPV) vaccine among girls rose from 27% in 2023 to 31% in 2024. Consequently, the expanding volume of vaccination initiatives is fueling the advancement of the shingles vaccine market.

Which Market Segments Are Examined In The Shingles Vaccine Market Study?

The shingles vaccine market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine

2) By Product: Shingrix, Zostavax, Skyzoster

3) By Age Group: 50-59 Years, 60-69 Years, 70 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End User: Hospitals, Clinics, Pharmacies

Subsegments:

1) By Live Attenuated Vaccine: Virus Strain A, Virus Strain B, Virus Strain C

2) By Recombinant Vaccine: Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine

3) By Subunit Vaccine: Protein Subunit Vaccine, Conjugate Subunit Vaccine

Which Trends Are Influencing The Shingles Vaccine Market?

Key companies operating in the shingles vaccine market are concentrating on developing innovative vaccine formulations, notably recombinant adjuvanted vaccines, to enhance immune response and provide long-lasting protection against shingles. Recombinant adjuvanted vaccines utilize laboratory-made viral proteins combined with substances known as adjuvants to bolster the body’s immune response for improved and extended protection. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, launched its shingles vaccine, Shingrix. Shingrix is an inactivated, recombinant adjuvanted subunit vaccine administered intramuscularly in two doses for individuals aged 50 and above, aimed at preventing shingles (herpes zoster) and its related complication, post-herpetic neuralgia. This highly effective vaccine delivers over 90% protection against shingles, ensuring strong and sustained immunity for at least 10 years, even in older adults and immunocompromised individuals.

Who Are The Primary Competitors In The Shingles Vaccine Market?

Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc

Read the full shingles vaccine market report here:

https://www.thebusinessresearchcompany.com/report/shingles-vaccine-global-market-report

What Are The Leading Geographic Regions In The Shingles Vaccine Market?

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Shingles Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27413&type=smp

Browse Through More Reports Similar to the Global Shingles Vaccine Market 2026, By The Business Research Company

Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-global-market-report

Folding Furniture Market Report 2026

https://www.thebusinessresearchcompany.com/report/folding-furniture-global-market-report

Foldable Houses Market Report 2026

https://www.thebusinessresearchcompany.com/report/foldable-houses-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795